# Another Heart Drug Fails, Shocking Cardiologists

> **Open Intelligence Dossier** · First detected: 2026-09-05 00:07 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Another Heart Drug Fails, Shocking Cardiologists" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Bloomberg.com, statnews.com, Reuters and Novartis. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff? | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQX0NZVjdNTFE1bXZtVjVnZ1FaMUxMc1U3OVRoN3BLNHhEZ1REV0hXdTVldzl4SnU4RUM3RkZZNVhQS3oweVhnRi1DamJMa0NPMnp6azdnUUlJUjVCOHFydnNCOUpRUnV3NXZ0b1pLVGtRUjk4b2ZRNlliRmgwMFl1R2l0Q3p0Uzg4UjJCZzMtSFpXcll4?oc=5) |
| Business Wire | Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) | [Source Link](https://news.google.com/rss/articles/CBMitwJBVV95cUxNN0FyWkhFa2VQUDB5QVBwWGRnVW93WnNYY3F3RjhlSmVrVm1aLVdjUVhXa3ZmeDFSblhJenZNNlRENE9XWnNkTGVHaURXYnhoMnhRcWNaN0QyaDJMaElSQ18yUkxKd1BwT1dPSXRVS09qTkpUeUFwZ2NLb0Q3eUR3QzNvV1AzUkdiOTkwd1R6QWRrY2dZc2plem5vNkxfeXZRUGlDZlA4bzdsZFBnMm5xa2ZxTmNqaXAtTG9aZWhpalRLWmNEUW4tdnZFcDNTVlRlZkd6dzBoNC1GZ01mSFZhMDZZYWNJYWIwcnY2Z0RrM1ZuRmdabGlCLW5ZZUZUN1pMc2VpM2pRanRtQkdmRFRSS2JxWHNCU3NDV2ZpMXJpb3JBdWFOdW1jUGFhMWFSNnNpWVRYd2Iwdw?oc=5) |
| GlobeNewswire | Novartis announces Lp(a)HORIZON Phase III topline results | [Source Link](https://news.google.com/rss/articles/CBMivwJBVV95cUxNeGNPR0NQNmVQWEd6ZUxfOEkyWTN3VlJkOXptZEE5d3RGMW5OSGNQRGt5eWU4TWlFM2pkTnJ6cExLcU1xMG5DQ24xRzdWeURvOWRFb3ZQUk9ITW9YaDBrUDF0N2FWMUQ1cXdvRGJfVUZ3T1BSUjNuT3JtOUExRjZLdW02SkRsclhWQ1NqTUNxNlMtc1BqT01lcmczajFjekN3SWo4X2F3ci1FN2RGZ1hWUWxKMnEwb3NHTlpwVHJ0Z0lZMW5Mdm1NYlMtVWgzOFpxYi1LcHhYa0Rzd2VFd1doYXJNQ2xQQmU0bzFETHJ2N0FQV2VMdTlobkFlQ0FFTEwxV0dDbEZRN2Q5WkV3Q2traVlUNS00R3VQZ0NhZXVXMW5iM0dMMXpDcWY1Qy1xclJvdElwb1NFTzktU25TV1Q4?oc=5) |
| WSJ | Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxOU0M0NElaRFRJdFpkVmN3TTU4UUlfTHNSQ0NkUVdPbk1RYXZvSmpxRkloMGZheFdkOFl2NFRYYVVVRVZiMVJlWnJVcnlEcjRaMlU3YnVLRThINVVteDZ6dlJfZGF5S05KQXlHM2xyNVRaa1h6TUprZXFoSHM1bGY0OXN4TEFPb2hVbWs3bUIwaV9DTlMyTGdWbDBRdjduNkVQbF9ORDFXLW9BT1RjLXJJ?oc=5) |
| WSJ | Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPTWxqSWplY21mUVFmelpyUm82aEdFOVNETndUR3o2OHRKZzhmbkRILWRia2VTZkg5OWJoc3M5ZjkzcVl5NzV5cEIwUVNwXzkwRGZYcjlRNERMdElDNFZCT3ppdzdVd0NpS3U3TlR3LVRGWVB0Y3FVVm5CYkN2eEhNMG9rU1AzNHAzYkZIVklhclJLcDFXRUJEaThwU0ttaWJWNEo0VDVPSzQxWlpOeHBJ?oc=5) |
| Bloomberg.com | Novartis Drug Fails Key Test for New Heart Disease Approach | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxORHpsbHUwbGNqWmFrQVNtTlQ0MkdfRzc3cDZ6blVCSzlYOTgzX2x1M3g0c0VGTGx5WEFadDR5MXhCeWdjTWkwdXhTZXBxUlBsX3RVdjJVc2RXd096bGZ6VlZOdUtyS2M4OXo1THkyN1FjSmVWc0E3eTNZREVndE54RWc5aEt5VVYyeW1PWkcwaURCZV91U1lFMHY0VzBJcjlScFlsbTkwcU5rTXgta2hvOVZB?oc=5) |
| statnews.com | Novartis’ experimental cardiovascular drug fails a pivotal study | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNR19WTW5hSlFaQmpudWxXa3ZCZmdRQm5qa0lnWlVRMlk2X3M3UzZvNnZoc3F0Z3NuTTJOdHhJRmVIMC1iWWN0bU9FUV9WOEs2MEdKY1ZzWEFsN3VGSUlkd3NxSGhLdjlibDNZbjllY0pRNDVtYnJaTXZwZHZpRVZlUGlGMFRrejA1U2l4UmJrVEFSZ1lnREE?oc=5) |
| Reuters | Ionis, Novartis' key experimental heart drug fails in late-stage trial | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOUxoV0pmRFpRcnNRQm1TU1N0YXF1RDE2RXp1RWE2NXF6UGJqU1hRYzFLMlhPRi1FZVotdTJjU0xsMVpoMnU2ZXM5UVlQbmFfYy16NGswZzJJUjNjUEJ3MVlfaUVFUU03OVpCblBmVUpEeUhFQkdWUnhjTWI5alBpa0c0cXRVQjE1QjFTQWZDTzh4cW11TEhURC12N0M5VU5pRWNyTUZYY3pxV3lqOG1jY2d5UEYycTlKLXJ6dWRodUttQWZVY194elJkNGJMNGpjem1v?oc=5) |
| Novartis | Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) | [Source Link](https://news.google.com/rss/articles/CBMihwJBVV95cUxPdUZZeEozUF81cXlUSnBVSzl0UlZ5UU5BT3Ezckw3Mm5rZDd1akxUM2dFaGhrMzJmNDQ0QklnNzZFNVBxbUdMeUYwTmh2ZWZWeW9qRVl0U0Nja2w0bGptLWtVZ3RQdUtGVHZEN3M4Y3pPMmtBanZ6d0NQNE5MY2JTdGVraHpQRGd0Z3p6QTVWTnVud3V2ZmdKN2hUM0pfSDNyR3o3dXROLVIwUzVZOE0xVjE0Y2dYeGpEZzV0ZUFaT1hGY0N5aC1BWXk1UzFWNFZSWHRoSmJaLUttb3JzcWNvb2xTSUVNMHViRW1WSTI2TXJkTEFSTjVsR1RYNWp1VWE5N2hVZG9vdw?oc=5) |
| nytimes.com | Another Heart Drug Fails, Shocking Cardiologists | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxPMU84YmlGWG5DMGlWQURBTjRwTEdwRXFYV1FWYllWcm04bGt3N09La0pIdE50X2hRaDMzRWVyUEt0MUxZMG5TWUE3YVlSUFdSWFR0ZjVoTUswMVdtekhQWUNSQUNvei1nR1BSQS00MnBGSGMzejdwR1Q4VS1qbDc2RHVJRlNLTlp3M055aQ?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-05/another-heart-drug-fails-shocking-cardiologists*